EARNINGS-BEAT

EARNINGS-BEAT

West Pharmaceutical Stock Gains on Q3 Earnings Beat & Raised Guidance

In a significant development that has sent shockwaves through the pharmaceutical industry, West Pharmaceutical Services, Inc. (WST) has reported a robust thirdquarter 2024 performance, surpassing market expectations. The company's adjusted earnings per share (EPS) of $1.85 not only exceeded analyst forecasts but also highlighted a promising trajectory for the full year..

EARNINGS-BEAT

West Pharmaceutical rises 15.2%

Introduction In a significant turn of events, West Pharmaceutical Services (WST) has experienced a substantial rise in its stock price, reaching a new high of $330.00 on October 24, 2024..